SciTech Patent Art is a global leader in technology and market intelligence and consulting services. We provide services focused on supplier due diligence, competitor intelligence, open innovation, partner identification and patent due diligence based on publicly available information. We rely on big data and machine learning tools to analyze publicly available information on clinical trials, FDA, EMA, PMDA and other similar agency disclosures, investor reports, websites, patents, technical articles and conference proceedings to extract insights. We have worked in domains such as drug delivery, biopharma, small- and large-molecule drugs, excipients, ADCs, and many other emerging areas.